14 results
ARS
2024 FY
ABSI
Absci Corp
23 Apr 24
Annual report to shareholders
4:10pm
and abuse, false claims, and transparency laws and regulations related to drug pricing and payments and other transfers of value made to physicians … and federal anti-kickback, fraud and abuse, false claims, and transparency laws and regulations related to drug pricing and payments and other transfers
ARS
2022 FY
ABSI
Absci Corp
28 Apr 23
Annual report to shareholders
12:00am
-kickback, fraud and abuse, false claims, and transparency laws and regulations related to drug pricing and payments and other transfers of value made … , and transparency laws and regulations related to drug pricing and payments and other transfers of value made to physicians and other healthcare
10-K
2021 FY
ABSI
Absci Corp
22 Mar 22
Annual report
5:20pm
, and transparency laws and regulations related to drug pricing and payments and other transfers of value made to physicians and other healthcare providers … with our customers and partners. Such laws include, without limitation, state and federal anti-kickback, fraud and abuse, false claims, and transparency
10-Q
t52b52316ik
7 Sep 21
Quarterly report
8:48am
424B4
9kp1trmq3 t7d0
23 Jul 21
Prospectus supplement with pricing info
4:49pm
S-1/A
57iht2 qerptfade2esp
8 Jul 21
IPO registration (amended)
5:04pm
S-1
mz837
30 Jun 21
IPO registration
3:20pm
DRS/A
83ds g086e
16 Jun 21
Draft registration statement (amended)
12:00am
DRS
dinc2bo0a9rbu77b
6 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next